From: Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders
Participant characteristics (N = 125) | |
---|---|
Age (years) | |
Mean (SD) | 40.9 (9.7) |
Median (range) | 40 (18–68) |
Gender [n (%)] | |
Female | 88 (70%) |
Male | 37 (30%) |
Race/ethnicity [n (%)] | |
White | 97 (78%) |
Mixed race | 13 (10%) |
Black | 6 (5%) |
Asian | 5 (4%) |
Hispanic | 3 (2%) |
Other | 1 (1%) |
Type of residential community [n (%)] | |
Suburban | 54 (43%) |
Rural | 38 (30%) |
Urban | 33 (27%) |
Number of overdose events in the past 12 months where participant has administered Narcan® Nasal Spray [n (%)] | |
1 | 49 (39%) |
2 | 41 (33%) |
3 | 14 (11%) |
≥ 4 | 21 (17%) |
Experienced an overdose themselves [n (%)] | |
Yes | 44 (35%) |
No | 81 (65%) |